Phase I study evaluating high-dose treatment with ADXS11-001, a Listeria monocytogenes-listeriolysin O (Lm-LLO) immunotherapy, in women with cervical cancer.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Sharad A. Ghamande, Daniel Platt, Donna Wheatley, Bunja Jane Rungruang, John Edward Janik, Samir Khleif
Institutions: Augusta University, Advaxis (United States)
Language: English
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2738410017